Financial results - TUVET PHARM S.R.L.

Financial Summary - Tuvet Pharm S.r.l.
Unique identification code: 27870680
Registration number: J38/1/2011
Nace: 4646
Sales - Ron
342.062
Net Profit - Ron
48.715
Employees
3
Open Account
Company Tuvet Pharm S.r.l. with Fiscal Code 27870680 recorded a turnover of 2024 of 342.062, with a net profit of 48.715 and having an average number of employees of 3. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Tuvet Pharm S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 25.667 43.600 52.384 145.465 291.847 271.693 154.363 182.527 225.975 342.062
Total Income - EUR 26.686 45.305 52.940 147.662 293.696 273.870 154.381 188.243 240.794 345.775
Total Expenses - EUR 21.100 34.585 41.341 128.376 245.952 228.008 152.125 173.964 204.000 288.243
Gross Profit/Loss - EUR 5.585 10.720 11.600 19.285 47.743 45.862 2.256 14.279 36.794 57.532
Net Profit/Loss - EUR 4.785 9.361 10.288 17.812 45.250 43.388 713 12.397 34.491 48.715
Employees 0 0 1 2 3 2 2 1 2 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 52.2%, from 225.975 euro in the year 2023, to 342.062 euro in 2024. The Net Profit increased by 14.416 euro, from 34.491 euro in 2023, to 48.715 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Tuvet Pharm S.r.l.

Rating financiar

Financial Rating -
TUVET PHARM S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Tuvet Pharm S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Tuvet Pharm S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Tuvet Pharm S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Tuvet Pharm S.r.l. - CUI 27870680

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 248 4.422 11.224 32.050 20.034 13.828 6.376 3.285 8.028
Current Assets 16.162 27.592 35.486 55.519 92.381 45.234 77.695 82.478 128.336 172.241
Inventories 7.987 15.183 18.621 30.102 32.694 17.330 43.847 38.353 41.575 56.404
Receivables 6.172 10.695 7.079 13.839 29.353 12.392 28.376 28.880 41.408 59.253
Cash 2.003 1.715 9.786 11.579 30.333 15.512 5.473 15.245 45.354 56.584
Shareholders Funds 11.281 20.527 30.467 47.720 86.988 43.430 43.179 55.710 90.033 133.874
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 5.047 7.477 9.602 19.478 38.790 23.311 49.797 34.495 42.936 47.735
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 172.241 euro in 2024 which includes Inventories of 56.404 euro, Receivables of 59.253 euro and cash availability of 56.584 euro.
The company's Equity was valued at 133.874 euro, while total Liabilities amounted to 47.735 euro. Equity increased by 44.345 euro, from 90.033 euro in 2023, to 133.874 in 2024.

Risk Reports Prices

Reviews - Tuvet Pharm S.r.l.

Comments - Tuvet Pharm S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.